| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.9M | +34.8% |
| R&D Expense | $37.6M | -42.2% |
| SG&A Expense | $19.0M | -5.9% |
| Operating Income | -$43.7M | +42.3% |
| Interest Expense | $2.3M | +15.2% |
| Income Tax | $0 | — |
| Net Income | -$43.6M | +43.7% |
| EPS (Basic) | -$1.34 | +44.9% |
| EPS (Diluted) | -$1.34 | +44.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.1M | -60.7% |
| Short-term Investments | $27.6M | +70.0% |
| Accounts Receivable | $2.2M | +3579.7% |
| Current Assets | $74.4M | -41.1% |
| Total Assets | $87.3M | -39.5% |
| Current Liabilities | $31.0M | -11.2% |
| Long-term Debt | $12.0M | -34.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.5M | +34.3% |
| Capital Expenditures | $537K | -70.7% |
| Investing Cash Flow | -$12.1M | +33.1% |
| Financing Cash Flow | -$1.6M | -203.3% |
| Free Cash Flow | -$52.0M | +35.2% |
| Total Liabilities |
| $48.1M |
| -28.4% |
| Stockholders' Equity | $39.1M | -49.3% |